Search research articles
Contact Us
Filters
Showing results (31-40 of 124) with videos related to
Page
of 13
Sort By:
Journal of Hematology
|
July 16, 2021
A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
Tina Ko, Crystal Seah, Michael Gilbertson, et al.
Journal of Medical Imaging and Radiation Oncology
|
June 16, 2012
Complete remission of localised gastric plasmacytomas following definitive radiotherapy
Jennifer Tan, Stephen Lade, Simon Harrison, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 3, 2013
Factor XIII assays
Stephen Opat, Jenny Butler, Erica Malan, et al.
Leukemia & Lymphoma
|
May 26, 2026
Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study
Zoe Loh, Eliza Chung, Cameron Wellard, et al.
Emerging Infectious Diseases
|
August 21, 2015
Disseminated Enteroviral Infection Associated with Obinutuzumab
Claire Dendle, Michael Gilbertson, Tony M Korman, et al.
Cold Spring Harbor Molecular Case Studies
|
August 27, 2020
Failure of tofacitinib to achieve an objective response in a <i>DDX3X-MLLT10</i> T-lymphoblastic leukemia with activating <i>JAK3</i> mutations
Jonathan Wong, Meaghan Wall, Gregory Philip Corboy, et al.
Leukemia & Lymphoma
|
October 29, 2009
Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Sushrut Patil, Andrew Spencer, Anthony Schwarer, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 7, 2019
Management of patients with follicular lymphoma treated first line with obinutuzumab
Stephen Opat, Michael Dickinson, Chan Yoon Cheah, et al.
Annals of Hematology
|
January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma
Pasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
Hemasphere
|
November 15, 2019
Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome
Jonathan Wong, Lawrence Cher, James Griffiths, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 124) with videos related to
Sort By:
Page
of 13
Journal of Hematology
|
July 16, 2021
A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
Tina Ko, Crystal Seah, Michael Gilbertson, et al.
Journal of Medical Imaging and Radiation Oncology
|
June 16, 2012
Complete remission of localised gastric plasmacytomas following definitive radiotherapy
Jennifer Tan, Stephen Lade, Simon Harrison, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 3, 2013
Factor XIII assays
Stephen Opat, Jenny Butler, Erica Malan, et al.
Leukemia & Lymphoma
|
May 26, 2026
Significant variations in first-line mantle cell lymphoma care-an Australasian Lymphoma and Related Diseases Registry study
Zoe Loh, Eliza Chung, Cameron Wellard, et al.
Emerging Infectious Diseases
|
August 21, 2015
Disseminated Enteroviral Infection Associated with Obinutuzumab
Claire Dendle, Michael Gilbertson, Tony M Korman, et al.
Cold Spring Harbor Molecular Case Studies
|
August 27, 2020
Failure of tofacitinib to achieve an objective response in a <i>DDX3X-MLLT10</i> T-lymphoblastic leukemia with activating <i>JAK3</i> mutations
Jonathan Wong, Meaghan Wall, Gregory Philip Corboy, et al.
Leukemia & Lymphoma
|
October 29, 2009
Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Sushrut Patil, Andrew Spencer, Anthony Schwarer, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 7, 2019
Management of patients with follicular lymphoma treated first line with obinutuzumab
Stephen Opat, Michael Dickinson, Chan Yoon Cheah, et al.
Annals of Hematology
|
January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma
Pasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
Hemasphere
|
November 15, 2019
Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome
Jonathan Wong, Lawrence Cher, James Griffiths, et al.
Page
of 13